These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7610920)

  • 21. Bone quality--the material and structural basis of bone strength and fragility.
    Seeman E; Delmas PD
    N Engl J Med; 2006 May; 354(21):2250-61. PubMed ID: 16723616
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone mineral density among postmenopausal Saudi women.
    Sadat-Ali M; Al-Habdan IM; Al-Mulhim FA; El-Hassan AY
    Saudi Med J; 2004 Nov; 25(11):1623-5. PubMed ID: 15573189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of age-related bone loss and bone fragility: an alternative view.
    Raisz LG; Seeman E
    J Bone Miner Res; 2001 Nov; 16(11):1948-52. PubMed ID: 11697790
    [No Abstract]   [Full Text] [Related]  

  • 24. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frequency of lumbar spine osteopenia in an asymptomatic postmenopausal Chilean population].
    Arteaga E; Campusano C; Rodríguez JA; Cervilla V; López JM; Valdivia G
    Rev Med Chil; 1994 Apr; 122(4):372-7. PubMed ID: 7809531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of modelling and remodelling on human vertebral body architecture.
    Mosekilde L
    Technol Health Care; 1998 Dec; 6(5-6):287-97. PubMed ID: 10100932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit.
    Martínez-Aguilà D; Gómez-Vaquero C; Rozadilla A; Romera M; Narváez J; Nolla JM
    J Rheumatol; 2007 Jun; 34(6):1307-12. PubMed ID: 17552058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretation of bone densitometry.
    Genant HK
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):20S-25S. PubMed ID: 9273933
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of raloxifene and clodronate on bone density in postmenopausal osteoporotic women.
    D'Amelio P; Muratore M; Tinelli F; Tamone C; Cosentino L; Quarta E; Calcagnile F; Carlo Isaia G
    Int J Tissue React; 2003; 25(2):73-8. PubMed ID: 14518596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis. Efficacy and safety of a bisphosphonate dosed once weekly.
    Baran D
    Geriatrics; 2001 Mar; 56(3):28-32. PubMed ID: 11252758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Routine examinations in the densitometry department].
    Gömör B; Lányi E
    Wien Med Wochenschr; 1999; 149(19-20):567-8. PubMed ID: 10637970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidants and bone turnover in involutional osteoporosis.
    Maggio D; Barabani M; Pierandrei M; Macchiarulo MC; Cecchetti R; Pedrazzoni M; Senin U; Cherubini A
    J Endocrinol Invest; 2002; 25(10 Suppl):101-2. PubMed ID: 12508937
    [No Abstract]   [Full Text] [Related]  

  • 34. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study.
    Garnero P; Borel O; Sornay-Rendu E; Arlot ME; Delmas PD
    J Bone Miner Res; 1996 Jun; 11(6):827-34. PubMed ID: 8725180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Osteoporosis--pathogenesis and prophylaxis].
    Skrzypulec V; Rozmus-Warcholińska W; Walaszek A; Drosdzol A; Nowosielski K; Piela B
    Wiad Lek; 2004; 57 Suppl 1():295-300. PubMed ID: 15884261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study.
    Hannan MT; Felson DT; Anderson JJ
    J Bone Miner Res; 1992 May; 7(5):547-53. PubMed ID: 1615761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Should one purchase a mineralometer for measuring bone mass?].
    Rivier E
    Rev Med Suisse Romande; 1991 Jun; 111(6):541-5. PubMed ID: 1862274
    [No Abstract]   [Full Text] [Related]  

  • 40. Osteoporosis and bisphosphonates.
    Rodan GA; Reszka AA
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():8-12. PubMed ID: 12925603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.